Tag:

Bristol-Myers Squibb

Latest Headlines

Latest Headlines

UPDATED: Bristol-Myers turns to Samsung for cancer drug

Samsung BioLogics has said that its manufacturing prowess will enable it to make biologic drugs more cheaply than about anyone else. Bristol-Myers Squibb intends to find out via a 10-year pact for making a yet-to-be-approved cancer drug.

BMS to put operations facility in Florida

Bristol-Myers Squibb will open a new facility in Florida to support operations, creating 575 jobs in the process.

Bristol-Myers Squibb moving 575 jobs to Tampa

A recent report put Bristol-Myers Squibb at the back of the line in terms of Big Pharma companies that are hiring right now. But that is of little interest to Florida, which just nabbed the company for a new development near Tampa that it promises to fill with more than 575 jobs.

Pfizer, Bristol-Myers eye Onyx deal as first-round bids loom

Street talk about Big Pharma bidders for Onyx Pharmaceuticals puts Pfizer and Bristol-Myers Squibb in the hunt, with biotech giant Amgen still leading the charge.

FDA report casts doubt on Chinese trial data

China has fast become a huge pillar on the global R&D scene, with local CROs like WuXi PharmaTech and ShangPharma cashing in on demand for clinical trials in the country. But, with the FDA chiding a sloppy Chinese trial run by Bristol-Myers Squibb, Pfizer and PPD, regulators and researchers may think twice before accepting data gathered in the country.

BMS, Pfizer say FDA to review Eliquis for new use

The FDA will consider Eliquis for a new indication, one which Pfizer and partner Bristol-Myers Squibb hope can help the blood thinner hit the sales potential analysts predicted for the drug before it was approved.

Data fraud allegedly delayed FDA nod for Pfizer-BMS drug Eliquis

The allegations could raise more questions about the integrity of drug research in China.

'Fraud' found at China site for key study of Pfizer and Bristol's Eliquis

Nearly 7 months since the FDA approved the blockbuster candidate Eliquis, media reports have shed light on data errors and a case of alleged fraud from clinical trial sites in China. The revelations in reports from Elsevier and Bloomberg could further harm the image of China as a hotspot for clinical development.

Who's hiring in Big Pharma? Novartis, Roche, Sanofi top the list

The world's biggest drugmakers are hiring--even in the U.S. and Europe. As  Genetic Engineering & Biotechnology News  numbers show, the three most active recruiters have more than 5,000 positions to fill between them.

Pfizer, Bristol-Myers tout new VTE data on Eliquis, aiming for new use

Pfizer and Bristol-Myers Squibb announced today that their anticoagulant drug Eliquis matched standard treatment for potentially life-threatening blood clots, efficacy-wise. And it beat warfarin on the safety side, with a 69% reduction in the risk of major bleeding.